一个有针对性的概率估计比较 cefepime 和 piperacillin/tazobactam 在社区获得性肺炎 (CAP) 的重症患者中
Cristian C Serrano-Mayorga1,2,3,4, Sara Duque1, Elsa D Ibáñez-Prada1,2,3
1Unisabana Center for Translational Science, Universidad de La Sabana, Chía, Colombia.
Scientific reports
|June 11, 2024
概括
塞菲皮姆和皮佩拉西林/塔扎巴克坦在重症监护室 (ICU) 患有社区获得性肺炎 (CAP) 的患者的死亡率相似. 治疗选择可能取决于诸如药物的可用性和安全性等因素.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 在重症监护室 (ICU) 的社区获得性肺炎 (CAP) 需要有效的实证抗菌疗法.
- 塞费皮姆和皮佩拉西林/塔扎巴克坦是指导方针推的选择,但临床偏好各不相同.
- 了解比较结果对于优化患者管理至关重要.
研究的目的:
- 为了比较cefepime与piperacillin/tazobactam在患有CAP的重症急症监护室患者中的有效性.
- 确定影响这两种抗菌剂之间的选择因素.
主要方法:
- 针对性最大概率估计 (TMLE) 用于比较分析.
- 分析了一组2026名ICU入院的CAP患者的队列.
- 记录了患者的特征,包括呼吸衰竭和感染性休克的发生率.
主要成果:
- 塞费皮姆 (Cefepime) 和皮佩拉西林/塔扎巴克坦 (Piperacillin/tazobactam) 治疗显示了可比的28天,医院和ICU死亡率.
- 诸如年龄,PTT,血清和温度等因素与首选塞费皮姆相关.
- 在两个治疗组之间没有观察到死亡率的显著差异.
结论:
- 塞费皮姆和皮佩拉西林/塔扎巴克坦在ICU患者中产生类似的死亡结果.
- 临床决策可能包括药物的可用性和安全性,以及疗效.
- 进一步的研究可以探索基于患者特定因素的细微治疗选择.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12.9K
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.7K
相关概念视频
01:28Pneumonia IV: Management
322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
01:30Pneumonia III: Complications and Assessment
200
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
200
01:30Pneumonia I: Introduction
221
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
221